Radiosynthesis of N-11C-meisoindigotin as a novel PET agent for imaging of cyclin-dependent kinases and GSK-3β
摘要:
Meisoindigotin has been demonstrated as a new type of cancer chemotherapeutic agent. N-C-11-meisoindigotin was synthesized by N-C-11-methylation of the isoindigotin precursor with C-11-labelled methyl triflate. The decay corrected radiochemical yields were 15-25%, and the specific radioactivity was 1.0-1.2 Ci/mu mol at the end of synthesis. The cellular uptake of [N-C-11]-meisoindigotin was evaluated in four different lung cancer cell lines. Our results showed that the A549, GLC-82, 95D cell lines exhibited higher uptake than 95C cell line after incubation for 60 min. N-C-11-meisoindigotin was a promising candidate for further development as a novel PET radiotracer for imaging of cyclin-dependent kinases (CDKs) and GSK-3 beta. (C) 2011 Jin Ming Zhang. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.